Suppl. Fig. 1-6 from Adapting a Drug Screening Platform to Discover Associations of Molecular Targeted Radiosensitizers with Genomic Biomarkers

Suppl. Fig. 1-6. Fig. S1. Testing and optimization of short-term cell survival assays. S2. SRF2Gy measurements and correlations. S3. Analysis of apoptosis after drug/IR treatments. S4. Analysis of senescence after drug/IR treatments. S5. Radiosensitizing effects of everolimus. S6. Radiosensitzing effects of midostaurin.